{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:16:39Z","timestamp":1785420999437,"version":"3.56.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Reproductive Immunology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jri.2025.104538","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T21:03:14Z","timestamp":1746738194000},"page":"104538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Immunological effects of GLP-1 analogs on female reproduction: Therapeutic perspectives for infertility and recurrent pregnancy loss"],"prefix":"10.1016","volume":"169","author":[{"given":"Ana Clara Muniz","family":"Tavares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Yzadora Moura","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle Ferreira","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduarda Maia","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Alves","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa Cruz","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia Machado Luz","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Oliveira","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9943-9731","authenticated-orcid":false,"given":"Marcelo Borges","family":"Cavalcante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"75","key":"10.1016\/j.jri.2025.104538_bib1","article-title":"GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review","volume":"30","author":"Alfaris","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jri.2025.104538_bib2","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3390\/cancers16081538","article-title":"From diabetes to oncology: glucagon-like peptide-1 (GLP-1) receptor agonist's dual role in prostate cancer","volume":"16","author":"Alhajahjeh","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jri.2025.104538_bib3","doi-asserted-by":"crossref","DOI":"10.23736\/S2724-6507.23.04101-5","article-title":"Exploring the potential impact of GLP-1 receptor agonists in cancer therapy","author":"Aslam","year":"2023","journal-title":"Minerva Endocrinol. (Torino)"},{"key":"10.1016\/j.jri.2025.104538_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.fertnstert.2019.11.025","article-title":"Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion","volume":"113","author":"ASRM","year":"2020","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2025.104538_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106320","article-title":"The anti-inflammatory and immunological properties of GLP-1 receptor agonists","volume":"182","author":"Bendotti","year":"2022","journal-title":"Pharm. Res"},{"key":"10.1016\/j.jri.2025.104538_bib6","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.3390\/ijms25094900","article-title":"Peptides are cardioprotective drugs of the future: the receptor and signaling mechanisms of the cardioprotective effect of glucagon-like peptide-1 receptor agonists","volume":"25","author":"Boshchenko","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.jri.2025.104538_bib7","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.fertnstert.2017.01.017","article-title":"Obesity and female infertility: potential mediators of obesity's impact","volume":"107","author":"Broughton","year":"2017","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2025.104538_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/aji.70060","article-title":"Immune treatment strategies in unexplained recurrent pregnancy loss","volume":"93","author":"Cai","year":"2025","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2025.104538_bib9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.fertnstert.2024.02.038","article-title":"Effectiveness of preconception weight loss interventions on fertility in women: a systematic review and meta-analysis","volume":"122","author":"Caldwell","year":"2024","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2025.104538_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.2021.4788","article-title":"Diagnosis and management of infertility: a review","volume":"326","author":"Carson","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jri.2025.104538_bib11","article-title":"The use of immunotherapies for recurrent miscarriage: an overview of systematic reviews and meta-analysis","volume":"158","author":"Cavalcante","year":"2023","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2025.104538_bib12","doi-asserted-by":"crossref","first-page":"103956","DOI":"10.1016\/j.jri.2023.103956","article-title":"Peripheral blood natural killer cell cytotoxicity in recurrent miscarriage: a systematic review and meta-analysis","volume":"158","author":"Cavalcante","year":"2023","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2025.104538_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13408","article-title":"Lymphocyte immunotherapy in recurrent miscarriage and recurrent implantation failure","volume":"85","author":"Cavalcante","year":"2021","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2025.104538_bib14","article-title":"Immune biomarkers in cases of recurrent pregnancy loss and recurrent implantation failure","author":"Cavalcante","year":"2024","journal-title":"Minerva Obstet. Gynecol."},{"key":"10.1016\/j.jri.2025.104538_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jog.13799","article-title":"Obesity and recurrent miscarriage: a systematic review and meta-analysis","volume":"45","author":"Cavalcante","year":"2019","journal-title":"J. Obstet. Gynaecol. Res"},{"key":"10.1016\/j.jri.2025.104538_bib16","doi-asserted-by":"crossref","first-page":"104157","DOI":"10.1016\/j.jri.2023.104157","article-title":"Calcineurin inhibitors in the management of recurrent miscarriage and recurrent implantation failure: systematic review and meta-analysis","volume":"160","author":"Cavalcante","year":"2023","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2025.104538_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.997578","article-title":"GLP-1 receptor agonist as a modulator of innate immunity","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.jri.2025.104538_bib18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/BF00281990","article-title":"New developments in the incretin concept","volume":"28","author":"Creutzfeldt","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.jri.2025.104538_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-083550","article-title":"Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services","volume":"14","author":"Dao","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.jri.2025.104538_bib20","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/apt.18138","article-title":"Use of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease","volume":"60","author":"Desai","year":"2024","journal-title":"Aliment Pharm. Ther."},{"key":"10.1016\/j.jri.2025.104538_bib21","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.3390\/nu16172886","article-title":"Subcutaneous semaglutide during breastfeeding: infant safety regarding drug transfer into human milk","volume":"16","author":"Diab","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.jri.2025.104538_bib22","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.jri.2025.104538_bib23","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/jama.2023.19897","article-title":"Obesity management in adults: a review","volume":"330","author":"Elmaleh-Sachs","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.jri.2025.104538_bib24","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1016\/S0021-9258(18)42531-8","article-title":"Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas","volume":"267","author":"Eng","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jri.2025.104538_bib25","article-title":"Obesity and female infertility","volume":"89","author":"Ennab","year":"2023","journal-title":"Best. Pr. Res Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.jri.2025.104538_bib26","unstructured":"FDA, 2005. Food and Drug Administration. Drug approval package. Victoza injection. \u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2010\/022341s000TOC.cfm\u3009, 2024 (accessed 30 December 2024)."},{"key":"10.1016\/j.jri.2025.104538_bib27","unstructured":"FDA, 2010. Food and Drug Administration. Approval of exenatide (byetta) for the treatment of type 2 diabetes. \u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2005\/021773_byettatoc.cfm\u3009, 2024 (accessed 30 December 2024)."},{"key":"10.1016\/j.jri.2025.104538_bib28","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3390\/ijms26031295","article-title":"Exploring the immunological aspects and treatments of recurrent pregnancy loss and recurrent implantation failure","volume":"26","author":"Garmendia","year":"2025","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.jri.2025.104538_bib29","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.fertnstert.2023.08.954","article-title":"The prevalence of sporadic and recurrent pregnancy loss","volume":"120","author":"Genovese","year":"2023","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2025.104538_bib30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.fertnstert.2024.05.154","article-title":"Treating obesity and fertility in the era of glucagon-like peptide 1 receptor agonists","volume":"122","author":"Goldberg","year":"2024","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2025.104538_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13757","article-title":"Obesity and recurrent miscarriage: the interconnections between adipose tissue and the immune system","volume":"90","author":"Gon\u00e7alves","year":"2023","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2025.104538_bib32","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2022.07.020","article-title":"Effects of preconception weight loss after lifestyle intervention on fertility outcomes and pregnancy complications","volume":"118","author":"Hoek","year":"2022","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2025.104538_bib33","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12929-024-01090-x","article-title":"Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease and Parkinson's disease","volume":"31","author":"Hong","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jri.2025.104538_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13325","article-title":"The effectiveness of weight-loss lifestyle interventions for improving fertility in women and men with overweight or obesity and infertility: a systematic review update of evidence from randomized controlled trials","volume":"22","author":"Hunter","year":"2021","journal-title":"Obes. Rev."},{"key":"10.1016\/j.jri.2025.104538_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"SURMOUNT-1 Investigators. Tirzepatide Once Weekly for the Treatment of Obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.jri.2025.104538_bib36","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.3390\/ijms23073451","article-title":"Glucagon-like Peptide-1 receptor agonists in the management of type 2 diabetes mellitus and obesity: the impact of pharmacological properties and genetic factors","volume":"23","author":"Klen","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.jri.2025.104538_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106550","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: implications for neurodegenerative disease treatment","volume":"186","author":"Kopp","year":"2022","journal-title":"Pharm. Res"},{"key":"10.1016\/j.jri.2025.104538_bib38","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0140-6736(87)91194-9","article-title":"Glucagon-like peptide-1 7-36: a physiological incretin in man","volume":"2","author":"Kreymann","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jri.2025.104538_bib39","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.fertnstert.2022.04.009","article-title":"The role of immunologic tests for subfertility in the clinical environment","volume":"117","author":"Kwak-Kim","year":"2022","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2025.104538_bib40","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1007\/s43032-021-00599-y","article-title":"The role of immune cells in recurrent spontaneous abortion","volume":"28","author":"Li","year":"2021","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.jri.2025.104538_bib41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cca.2022.04.234","article-title":"Immune regulation in polycystic ovary syndrome","volume":"531","author":"Luan","year":"2022","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jri.2025.104538_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6616693","article-title":"The antiobesity effect of GLP-1 receptor agonists alone or in combination with metformin in overweight \/obese women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"2021","author":"Lyu","year":"2021","journal-title":"Int J. Endocrinol."},{"key":"10.1016\/j.jri.2025.104538_bib43","article-title":"The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: a meta-analysis of randomized controlled trials","volume":"38","author":"Morais","year":"2024","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.jri.2025.104538_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1215356","article-title":"Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence","volume":"14","author":"Muller","year":"2023","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jri.2025.104538_bib45","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/humupd\/dmae008","article-title":"Comparative efficacy of exercise, diet and\/or pharmacological interventions on BMI, ovulation, and hormonal profile in reproductive-aged women with overweight or obesity: a systematic review and network meta-analysis","volume":"30","author":"Ruiz-Gonz\u00e1lez","year":"2024","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.jri.2025.104538_bib46","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1600-0897.2010.00852.x","article-title":"Th1\/Th2\/Th17 and regulatory T-cell paradigm in pregnancy","volume":"63","author":"Saito","year":"2010","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2025.104538_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-18-0175","article-title":"Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study","volume":"179","author":"Salamun","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jri.2025.104538_bib48","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.7326\/M23-3179","article-title":"Effect of weight loss interventions on the symptomatic burden and biomarkers of polycystic ovary syndrome: a systematic review of randomized controlled trials","volume":"177","author":"Scragg","year":"2024","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.jri.2025.104538_bib49","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1001\/jama.2024.18207","article-title":"Ovarian aging and fertility","volume":"332","author":"Seifer","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jri.2025.104538_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113537","article-title":"Neuroprotective effects of GLP-1 receptor agonists in neurodegenerative disorders: a large-scale propensity-matched cohort study","volume":"143","author":"Siddeeque","year":"2024","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.jri.2025.104538_bib51","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/aogs.15010","article-title":"The hidden impact of GLP-1 receptor agonists on endometrial receptivity and implantation","volume":"104","author":"Sola-Leyva","year":"2025","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.jri.2025.104538_bib52","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 International evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jri.2025.104538_bib53","first-page":"1678","article-title":"Cloning and functional expression of the human islet GLP-1 receptor","volume":"42","author":"Thorens","year":"1993","journal-title":"Demonstr. that exendin-4 Is. agonist exendin-(9-39) Antagon. Recept. Diabetes"},{"key":"10.1016\/j.jri.2025.104538_bib54","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s43440-024-00629-x","article-title":"A review of serious adverse events linked with GLP-1 agonists in type 2 diabetes mellitus and obesity treatment","volume":"76","author":"Tobaiqy","year":"2024","journal-title":"Pharm. Rep."},{"key":"10.1016\/j.jri.2025.104538_bib55","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1080\/13813455.2024.2380422","article-title":"Efficacy and safety of glucagon-like peptide-1 receptor agonists in the treatment of polycystic ovary syndrome-A systematic review and meta-analysis","volume":"130","author":"Tong","year":"2024","journal-title":"Arch. Physiol. Biochem"},{"key":"10.1016\/j.jri.2025.104538_bib56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/imr.13080","article-title":"Monocytes and macrophages in pregnancy: the good, the bad, and the ugly","volume":"308","author":"True","year":"2022","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jri.2025.104538_bib57","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41569-023-00849-3","article-title":"Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action","volume":"20","author":"Ussher","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jri.2025.104538_bib58","doi-asserted-by":"crossref","DOI":"10.1111\/aogs.15060","article-title":"Ensuring safety first: GLP-1RAs in reproductive and endometrial research","author":"Vigan\u00f2","year":"2025","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.jri.2025.104538_bib59","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.2021.1831","article-title":"Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial","volume":"325","author":"Wadden","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jri.2025.104538_bib60","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3389\/fimmu.2020.02025","article-title":"T Helper (Th) cell profiles in pregnancy and recurrent pregnancy losses: Th1\/Th2\/Th9\/Th17\/Th22\/Tfh cells","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jri.2025.104538_bib61","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-5793(94)01430-9","article-title":"Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences","volume":"358","author":"Wei","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jri.2025.104538_bib62","first-page":"247","article-title":"recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Modifications recommended by FIGO as amended October 14, 1976","volume":"56","author":"WHO","year":"1977","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.jri.2025.104538_bib63","unstructured":"WHO, 2023. Infertility prevalence estimates, 1990\u20132021. Geneva: World Health Organization; 2023. \u3008https:\/\/www.who.int\/publications\/i\/item\/978920068315\u3009, 2023 (accessed 30 December 2024)."},{"key":"10.1016\/j.jri.2025.104538_bib64","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/ACI.0000000000000797","article-title":"Evaluating the glucagon-like peptide-1 receptor in managing asthma","volume":"22","author":"Wu","year":"2022","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.jri.2025.104538_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156038","article-title":"Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trials","volume":"161","author":"Xie","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.jri.2025.104538_bib66","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1080\/08820139.2021.1909061","article-title":"Fetomaternal immune tolerance: crucial mechanisms of tolerance for successful pregnancy in humans","volume":"51","author":"Yousefzadeh","year":"2022","journal-title":"Immunol. Invest"},{"key":"10.1016\/j.jri.2025.104538_bib67","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2337\/db14-1577","article-title":"GLP-1R Agonists modulate enteric immune responses through the intestinal intraepithelial lymphocyte GLP-1R","volume":"64","author":"Yusta","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.jri.2025.104538_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.994888","article-title":"Decidual macrophages in recurrent spontaneous abortion","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.jri.2025.104538_bib69","article-title":"The safety profile of usage of glucagon-like peptide-1 receptor agonists in pregnancy: a pharmacovigilance analysis based on the Food and Drug Administration Adverse Event Reporting System","author":"Zhou","year":"2024","journal-title":"Br. J. Clin. Pharm."}],"container-title":["Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037825001160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037825001160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T13:29:32Z","timestamp":1748525372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165037825001160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":69,"alternative-id":["S0165037825001160"],"URL":"https:\/\/doi.org\/10.1016\/j.jri.2025.104538","relation":{},"ISSN":["0165-0378"],"issn-type":[{"value":"0165-0378","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunological effects of GLP-1 analogs on female reproduction: Therapeutic perspectives for infertility and recurrent pregnancy loss","name":"articletitle","label":"Article Title"},{"value":"Journal of Reproductive Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jri.2025.104538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104538"}}